Demant A/S: Investor news - comparative figures for 2021
|
Investor news |
12 August 2022 |
Comparative figures for 2021
On 27 April 2022, Demant announced the decision to discontinue its Hearing Implants business. In accordance with IFRS 5 – Non-current Assets Held for Sale and Discontinued Operations and as previously communicated, Hearing Implants is therefore recognised in the Group’s financial reporting and statements as a discontinued operation, and comparative figures for 2021 are restated to reflect this. To help reconcile such restated figures with reported figures, we attach restated income statements (unaudited) for the following reporting periods: H1 2021, H2 2021 and FY 2021.
Please note that the attachment only includes historical figures in order to ease the comparison between historical and future performance.
|
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 |
Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Trine Kromann-Mikkelsen, VP Corporate Communication and Relations |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom